Michael Minshall

Michael holds a Bachelor of Science degree in biology (1986) from Alma College (Alma, Michigan) and a Master’s in Public Health (MPH) degree in epidemiology (1990) from the University of Texas Health Science Center at Houston. Michael has been in the health economics and outcomes research (HEOR) field for the past 32+ years. Prior to his current role at Zambon Pharmaceuticals, Michael held consulting positions with CTI Clinical Trial and Consulting and Certara. Michael held positions in the medical device industry with Sight Sciences, DJO Global and Covidien and also at Humana in the Comprehensive Health Insights subsidiary. Michael has also started HEOR consultancies and worked for larger ones. Michael started his HEOR career in the pharmaceutical industry at Eli Lilly and Company. Michael has authored a vast quantity of peer-reviewed medical communications and has been a reviewer for several health outcomes research journals. Michael is a member of the editorial advisory boards for Expert Review of Pharmacoeconomics & Outcomes Research and The Open Pharmacoeconomics & Health Economics Journal.